東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

The discontinuance of innovations in...

Holness, David A.

FindBook

Google Book

Amazon

博客來

The discontinuance of innovations in pharmaceutical labeling.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	The discontinuance of innovations in pharmaceutical labeling./
作者:	Holness, David A.
面頁冊數:	123 p.
附註:	Source: Dissertation Abstracts International, Volume: 65-05, Section: A, page: 1871.
Contained By:	Dissertation Abstracts International65-05A.
標題:	Business Administration, Marketing. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3132805
ISBN:	0496800450

The discontinuance of innovations in pharmaceutical labeling.
Holness, David A.

The discontinuance of innovations in pharmaceutical labeling. - 123 p.

Source: Dissertation Abstracts International, Volume: 65-05, Section: A, page: 1871.

Thesis (D.B.A.)--Nova Southeastern University, 2004.

This dissertation is about the discontinuance of innovations affecting the labeling for pharmaceutical products. Current FDA regulations in the Code of Federal Regulations (CFR) state that the "Labeling on or within the package from which the drug is dispensed bears adequate information for its use..." (21 CFR 201.100) Since it is physically attached to the product, full prescribing information is available to the pharmacist dispensing the drug.

ISBN: 0496800450Subjects--Topical Terms:

1017573
Business Administration, Marketing.

The discontinuance of innovations in pharmaceutical labeling.
LDR:03082nmm 2200301 4500 001 1852035
005 20051229075125.5
008 130614s2004 eng d
020 $a 0496800450
035 $a (UnM)AAI3132805
035 $a AAI3132805
040 $a UnM $c UnM
100 1 $a Holness, David A. $3 1939911
245 1 4 $a The discontinuance of innovations in pharmaceutical labeling.
300 $a 123 p.
500 $a Source: Dissertation Abstracts International, Volume: 65-05, Section: A, page: 1871.
502 $a Thesis (D.B.A.)--Nova Southeastern University, 2004.
520 $a This dissertation is about the discontinuance of innovations affecting the labeling for pharmaceutical products. Current FDA regulations in the Code of Federal Regulations (CFR) state that the "Labeling on or within the package from which the drug is dispensed bears adequate information for its use..." (21 CFR 201.100) Since it is physically attached to the product, full prescribing information is available to the pharmacist dispensing the drug.
520 $a In 1999, a proposal was submitted to the FDA by the Pharmaceutical Research Manufacturers of America, (PhRMA) a lobby representing the country's leading research-based pharmaceutical and biotechnology companies to replace the paper labeling with an electronic version of the full prescribing information. This document is labeled Appendix A. The innovations recommended by this proposal are intended to improve the timeliness of drug information delivered to dispensing sites.
520 $a Also, the innovations are intended to eliminate much of the material costs associated with the production, storage and distribution of drug labeling. If adopted, the PhRMA paperless labeling proposal may require a change to the federal regulation governing food and drug labeling. This dissertation researches the adoption response by the pharmaceutical dispensing community for this innovation suggested to improve pharmaceutical labeling.
520 $a Consistent with Rubin, (1995) qualitative interviewing was used in this dissertation due to the richness of knowledge gained from documentation, archival records, interviews, direct observations, participative observations, and physical artifacts within and governing the pharmaceutical labeling community. This research has also used a grounded theory approach as the basis for this research. According to Strauss and Corbin, (1994) this utilizes "the development or generation of a theory closely related to the context of the phenomenon being described." Pharmacists were examined using a questionnaire and others in the industry were examined through in-depth interviews. The findings from both approaches were congruent and support the null hypothesis that Rogers five and Moore Benbasat's two factors are predictors for the innovation's adoption.
590 $a School code: 1191.
650 4 $a Business Administration, Marketing. $3 1017573
650 4 $a Health Sciences, Pharmacy. $3 1017737
650 4 $a Computer Science. $3 626642
690 $a 0338
690 $a 0572
690 $a 0984
710 2 0 $a Nova Southeastern University. $3 1017571
773 0 $t Dissertation Abstracts International $g 65-05A.
790 $a 1191
791 $a D.B.A.
792 $a 2004
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3132805